Anthony Gilbert

4.0k total citations · 1 hit paper
30 papers, 2.1k citations indexed

About

Anthony Gilbert is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Anthony Gilbert has authored 30 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Anthony Gilbert's work include Influenza Virus Research Studies (23 papers), Respiratory viral infections research (18 papers) and Viral gastroenteritis research and epidemiology (6 papers). Anthony Gilbert is often cited by papers focused on Influenza Virus Research Studies (23 papers), Respiratory viral infections research (18 papers) and Viral gastroenteritis research and epidemiology (6 papers). Anthony Gilbert collaborates with scholars based in United States, United Kingdom and Belgium. Anthony Gilbert's co-authors include Rob Lambkin‐Williams, John Oxford, Tom Wilkinson, Tao Dong, Cecilia Chui, Xiao-Ning Xu, Andrew J. McMichael, Karl J. Staples, Daniel C. Douek and Molly Perkins and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and PLoS ONE.

In The Last Decade

Anthony Gilbert

29 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

2012 766 citations Tom Wilkinson, Cecilia Chui et al. Nature Medicine profile →

Peers

Countries citing papers authored by Anthony Gilbert

Since Specialization

Citations

This map shows the geographic impact of Anthony Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Gilbert more than expected).

Fields of papers citing papers by Anthony Gilbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Gilbert. The network helps show where Anthony Gilbert may publish in the future.

Co-authorship network of co-authors of Anthony Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Gilbert. A scholar is included among the top collaborators of Anthony Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Gilbert. Anthony Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Brief History of Human Challenge Studies (1900–2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D’etre, Ethnography, Selection of Volunteers and Unit Design 2022 ·Current topics in microbiology and immunology ·John Oxford, Anthony Catchpole, Anita Mann, (unknown), Nicolas Noulin, Débora Gil, (unknown), Anthony Gilbert, Shobana Balasingam	1
2	SARS-CoV-2 Human Challenge Studies — Establishing the Model during an Evolving Pandemic 2021 ·New England Journal of Medicine ·Garth Rapeport, Emma Smith, Anthony Gilbert, Andrew Catchpole, Helen McShane, Christopher Chiu	31
3	Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases 2020 ·Influenza and Other Respiratory Viruses ·P. Jacob Bueno de Mesquita, Jonathan S. Nguyen‐Van‐Tam, Ben Killingley, Joanne Enstone, Rob Lambkin‐Williams, Anthony Gilbert, Alex Mann, John Forni, Jing Yan, Jovan Pantelic, Michael L. Grantham, Donald K. Milton	5
4	Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment 2020 ·PLoS Pathogens ·Jonathan S. Nguyen‐Van‐Tam, Ben Killingley, Joanne Enstone, Michael P. Hewitt, Jovan Pantelic, Michael L. Grantham, P. Jacob Bueno de Mesquita, Rob Lambkin‐Williams, Anthony Gilbert, Alex Mann, John Forni, Catherine J. Noakes, Min Z. Levine, LaShondra Berman, Stephen Lindstrom, Simon Cauchemez, Werner Bischoff, Raymond Tellier, Donald K. Milton	18
5	Minimal Transmission in an Influenza A (H3N2) Human Challenge-Transmission Model with Exposure Events in a Controlled Environment 2019 ·SSRN Electronic Journal ·Jonathan S. Nguyen‐Van‐Tam, Ben Killingley, Joanne Enstone, Michael P. Hewitt, Jovan Pantelic, Michael L. Grantham, P. Jacob Bueno de Mesquita, Rob Lambkin‐Williams, Anthony Gilbert, Alex Mann, John Forni, Catherine J. Noakes, Min Z. Levine, LaShondra Berman, Stephen Lindstrom, Simon Cauchemez, Werner Bischoff, Raymond Tellier, Donald K. Milton	1
6	The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics 2018 ·Respiratory Research ·Rob Lambkin‐Williams, Nicolas Noulin, Alex Mann, Andrew Catchpole, Anthony Gilbert	43
7	The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process 2018 ·BMC Research Notes ·Andrew Catchpole, (unknown), Nicolas Noulin, Alex Mann, Anthony Gilbert, Rob Lambkin‐Williams	6
8	The effective rate of influenza reassortment is limited during human infection 2017 ·PLoS Pathogens ·(unknown), Micah T. McClain, Gavin J. D. Smith, David E. Wentworth, Rebecca Halpin, Xudong Lin, Amy Ransier, Timothy B. Stockwell, Suman R. Das, Anthony Gilbert, Rob Lambkin‐Williams, Geoffrey S. Ginsburg, Christopher W. Woods, Katia Koelle, Christopher J. R. Illingworth	33
9	A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model 2016 ·PLoS ONE ·(unknown), (unknown), Julie Mori, Andrew Catchpole, (unknown), Edward J. Murray, Ganesh Balaratnam, Anthony Gilbert, Alex Mann, (unknown), Rob Lambkin‐Williams	5
10	Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model 2016 ·PLoS ONE ·(unknown), Nicolas Noulin, Andrew Catchpole, Hosnieh Fathi, Edward J. Murray, Alex Mann, (unknown), Ganesh Balaratnam, (unknown), Anthony Gilbert, Rob Lambkin‐Williams	9
11	A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans 2015 ·Clinical and Vaccine Immunology ·Olga Pleguezuelos, Stuart Robinson, Ana M. Fernández, Gregory Stoloff, Alex Mann, Anthony Gilbert, Ganesh Balaratnam, Tom Wilkinson, Rob Lambkin‐Williams, John Oxford, Wilson Caparrós‐Wanderley	55
12	Virus-Specific Antibody Secreting Cell, Memory B-cell, and Sero-Antibody Responses in the Human Influenza Challenge Model 2014 ·The Journal of Infectious Diseases ·(unknown), (unknown), Elizabeth Clutterbuck, Cecilia Chui, Tom Wilkinson, Anthony Gilbert, John Oxford, Rob Lambkin‐Williams, Tzou‐Yien Lin, Andrew J. McMichael, Xiao-Ning Xu	43
13	RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus 2013 ·European Respiratory Journal ·Lindsey Cass, Kazuhiro Ito, Catherine E. Charron, Pete Strong, (unknown), Anthony Gilbert, Rob Lambkin‐Williams, Alex Mann, Garth Rapeport	3
14	Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections 2013 ·Journal of Clinical Virology ·Micah T. McClain, Lawrence P. Park, Bradly P. Nicholson, Timothy Veldman, Aimee K. Zaas, R. Jay Turner, Rob Lambkin‐Williams, Anthony Gilbert, Geoffrey S. Ginsburg, Christopher W. Woods	56
15	A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2 2013 ·PLoS ONE ·Christopher W. Woods, Micah T. McClain, Minhua Chen, Aimee K. Zaas, Bradly P. Nicholson, Jay B. Varkey, Timothy Veldman, Stephen F. Kingsmore, Yongsheng Huang, Rob Lambkin‐Williams, Anthony Gilbert, Alfred O. Hero, Elizabeth Ramsburg, Seth W. Glickman, Joseph E. Lucas, Lawrence Carin, Geoffrey S. Ginsburg	122
16	Comparing Influenza and Rsv Viral and Disease Dynamics in Experimentally Infected Adults Predicts Clinical Effectiveness of Rsv Antivirals 2013 ·Antiviral Therapy ·Bindiya Bagga, Christopher W. Woods, Timothy Veldman, Anthony Gilbert, Alex Mann, Ganesh Balaratnam, Rob Lambkin‐Williams, John Oxford, Micah T. McClain, Tom Wilkinson, (unknown), Geoffrey S. Ginsburg, John P. DeVincenzo	52
17	Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans breakdown → 2012 ·Nature Medicine ·Tom Wilkinson, (unknown), Cecilia Chui, Ang Huang, Molly Perkins, (unknown), Rob Lambkin‐Williams, Anthony Gilbert, John Oxford, Ben Nicholas, Karl J. Staples, Tao Dong, Daniel C. Douek, Andrew J. McMichael, Xiao-Ning Xu	766
18	Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans 2012 ·Clinical Infectious Diseases ·Patrick Lillie, Tamara Berthoud, Timothy J. Powell, Teresa Lambe, Caitlin E. Mullarkey, Alexandra J. Spencer, Matthew M. Hamill, Yanchun Peng, (unknown), C.J. Duncan, Susanne H. Sheehy, Tom Havelock, Saul N. Faust, (unknown), Anthony Gilbert, John Oxford, Tao Dong, Adrian V. S. Hill, Sarah C. Gilbert	209
19	Use of a Human Influenza Challenge Model to Assess Person-to-Person Transmission: Proof-of-Concept Study 2011 ·The Journal of Infectious Diseases ·Ben Killingley, Joanne Enstone, Jane Greatorex, Anthony Gilbert, Rob Lambkin‐Williams, Simon Cauchemez, Jacqueline M. Katz, Robert Booy, Andrew Hayward, John Oxford, Carolyn B. Bridges, Neil M. Ferguson, Jonathan S. Nguyen‐Van‐Tam	48
20	Gene Expression Signatures Diagnose Influenza and Other Symptomatic Respiratory Viral Infections in Humans 2009 ·Cell Host & Microbe ·Aimee K. Zaas, Minhua Chen, Jay B. Varkey, Timothy Veldman, Alfred O. Hero, Joseph E. Lucas, Yongsheng Huang, Ronald B. Turner, Anthony Gilbert, Rob Lambkin‐Williams, (unknown), Bradly P. Nicholson, Stephen F. Kingsmore, Lawrence Carin, Christopher W. Woods, Geoffrey S. Ginsburg	281

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact